Objectives: To construct and validate a model and derive a simple rule that is usable in any birth location for the prediction of outcome of term infants with severe asphyxia.
A PPROXIMATELY 23% OF THE 4 million annual global neonatal deaths are attributable to asphyxia. 1 Postasphyxial hypoxic-ischemic encephalopathy (HIE) occurs in approximately 1 to 2 infants per 1000 live term births. 2 Significant proportions of these infants die or survivewithseverelong-termmorbidity.Among term infants, 6% to 23% of cases of cerebral palsy (CP) are attributable to intrapartum asphyxia. 3, 4 Predictionsoflong-termoutcome in the immediate neonatal period are based on clinical, [5] [6] [7] biochemical, 8, 9 electrophysiological, 10, 11 and imaging 12 findings. The predictive accuracy in the very early postnatal period is moderate. 5, 13 Higher positive predictive values might be achieved with amplitude-integrated electroencephalography (EEG), but it is not available in many hospitals globally.
Certain strategies in experimental postasphyxial HIE prevent secondary neuronal injury when given within the therapeutic window of 5 to 6 hours from the insult. 14 Trials of hypothermia in humans have used clinicaland/oramplitude-integratedEEGcriteria for inclusion. [15] [16] [17] The choice of predictive inclusion criteria in research involves ethical and clinical considerations. 18 Early evaluation of risk is essential for appropriate selection of patients for neuroprotective therapies. 19 To decide on neuroprotective therapy within or outside of clinical trials, easily available, robust, and accurate prediction models are needed, preferably by age 4 hours to allow time for enrollment. Such a rule will also help to monitor the efficacy of interventions and for prognostication.
The objectives of this study were to develop and validate a prognostic model for term infants with postasphyxial HIE based on clinical and laboratory information available by age 4 hours and to develop a simple prediction rule based on the variables identified in the model.
INCLUSION CRITERIA
The following inclusion criteria were adapted from the American College of Obstetricians and Gynecologists 20 and Society of Obstetricians and Gynecologists of Canada 21 statements. Infants who had an acute perinatal event were eligible if they met the following 3 criteria: (1) Apgar score of less than 5 at 5 minutes, metabolic acidosis (base deficit Ͼ16 mmol/L) in cord arterial blood or the first postnatal blood gas sample within 4 hours of birth, or delayed onset of breathing for more than 5 minutes; (2) need for mechanical ventilation immediately after birth; and (3) moderate to severe encephalopathy including altered state of consciousness and/or seizures. 22 All of the infants had multisystem involvement 23 (encephalopathy and more than 1 other organ involved) identified as defined in Table 1 . This was determined from the data beyond age 4 hours to ensure appropriate inclusion.
EXCLUSION CRITERIA
Infants with encephalopathies associated with preterm birth, congenital abnormalities including subtle dysmorphism of unknown significance, a major single-organ anomaly, inborn errors of metabolism, congenital viral infection, septic shock, or cranial birth trauma, patients with evidence of antenatal events causing prenatal injury such as prolonged loss of fetal movements, arthrogryposis, or lack of fetal heart rate variability on admission of the mother to the hospital, and patients with severe meconium aspiration syndrome with persistent and prolonged postnatal hypoxemia were excluded to avoid the confounding effects on brain outcomes.
NEONATAL DATA
Data were collected on custom-made forms from the patients' records by fully trained neonatal transport team members. 24, 25 Data related to the maternal medical history, obstetric history, intrapartum details, and details of the resuscitation were collected. The time of onset of gasping, irregular breathing, regular breathing, or spontaneous breathing was recorded as available both in ventilated as well as unventilated infants. The age at onset of regular respiration was defined as the age at onset of spontaneous or regular breathing. The transport team members examined and recorded the neurological condition of the infant soon after arrival at the hospital of birth. The initial and subsequent neurological data included level of consciousness, presence of spontaneous movements and coma, altered muscle tone, the age at onset of seizures (subtle or tonic-clonic), and number and dosage of anticonvulsants received. This information along with a clinical description of the attending team was considered for determination of the degree of encephalopathy, which was classified according to the criteria by Sarnat and Sarnat. 22 None of the patients received prophylactic anticonvulsants. Use of muscle relaxants was not routine. Where data were available, the time course of the asphyxial insult was categorized for each subject as prolonged, acute near-total, or combined. 25 Two of us (P.S. and M.P.) assigned the time course of each subject independently, and discrepancies were resolved by consensus. When consensus was not reached or the time course could not be classified owing to insufficient data, the time course was categorized as indeterminate (Table 1 ). Blood gas analyses were performed at variable times during the first 4 hours after birth; therefore, each base deficit value was converted to the number of SDs from the mean normal values of full-term newborns for age at sampling 26 (z score).
OUTCOME DATA
Severe adverse outcome was defined in the research protocol as death or severe neurodevelopmental disability in survivors that was attributable to intrapartum asphyxial HIE. Cerebral palsy was defined as mild, moderate, or severe as suggested by Capute et al. 27 Developmental delay was defined as mild (developmental quotient, 81-90), moderate (developmental quotient, 71-80), or severe (developmental quotient, Ͻ70). Severe neurodevelopmental disability was defined as the following: (1) severe CP (probably nonambulatory) diagnosed by age 12 months by certified physical or occupational therapists and a Prolonged partial asphyxia (as per criteria outlined earlier) followed by acute near-total asphyxia, or the reverse pediatrician; (2) mild or moderate CP (likely ambulatory) but with severe cortical blindness or severe sensorineural deafness; or (3) moderate CP and suspected moderate or severe developmental delay at age 12 months confirmed by developmental testing between ages 18 and 36 months by certified occupational therapists or psychologists (Bayley scores Ͼ2 SD below the mean). The remaining children were classified as free of severe adverse outcome rather than good outcome, as some of these patients had minor disabilities. 28 All of the children with suspected motor or cognitive impairments were assessed by audiologists and ophthalmologists. Data regarding persistence of seizures and microcephaly were collected.
The outcome data were ascertained from health records of the neonatal follow-up clinic, neurology clinics, and readmissions when available. The neonatal follow-up clinic routinely assesses infants who had neonatal HIE at ages 4, 8, 12 , and 18 to 24 months. If developmental delay or motor deficit was suspected on clinical grounds or on the basis of screening tests, developmental tests were performed at ages 18 to 30 months. Children unable to perform the developmental assessment tests owing to physical or cognitive deficits were classified in the severe adverse outcome group. The procedure for obtaining data for patients with incomplete follow-up was described previously. 24 The study was approved by the institutional research ethics board.
STATISTICAL ANALYSES AND SAMPLE SIZE
Data were analyzed using SPSS version 12 statistical software (SPSS, Inc, Chicago, Ill). Patients with missing outcome data were excluded from analyses. Available data from patients with missing data were evaluated for randomness. Owing to the finding of nonrandomness of missing data, values were not imputed. Potential predictors selected on the basis of PϽ.10 in univariate logistic regression analyses were entered into multivariable models, and the odds ratios and 95% confidence intervals were computed. Goodness of fit of the model was assessed by the Hosmer-Lemeshow statistic and receiver operating characteristic curve. Internal validation was performed using 2 methods: (1) on a randomly selected derivation cohort comprising 70% of the cases and a validation cohort of the remaining 30%; and (2) temporally based by year of birth (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) as the derivation cohort and 1996-2000 as the validation cohort). Eight variables selected by univariate analyses were entered into the multivariate model. The sample size was adequate for the logistic model, as the number of events per variable exceeded 12 for both outcome categories. 29 An additional stepwise prediction rule was created using the 3 variables identified in multivariate logistic regression analysis to have the highest statistical significance based on the presence of none, any 1 or 2, or all of the 3 of these predictor variables, similar to the method used by Schmidt et al. 30 Predicted probabilities were then computed and compared with observed outcome rates. Likelihood ratios were calculated.
RESULTS

INFANTS
A total of 1195 patient records with relevant diagnoses (birth asphyxia, asphyxia, HIE, birth hypoxia, perinatal depression, brain anoxia, hypoxic-ischemic encephalopathy, or hypoxic encephalopathy) were reviewed; 375 patients met the eligibility criteria. Most of the exclusions (n=656) were owing to failure to meet the primary criteria of respiratory and/or neurological depression. These included most admissions with meconium aspiration syndrome. The remaining cases lacked evidence of moderate to severe encephalopathy (n = 90) or had hemorrhagic shock (n = 29), lack of fetal heart rate reactivity or absent fetal heart rate on admission (n=18), cranial trauma (n=17), congenital malformations (n=9), and congenital viral infection (n=1). The mean number of patients with moderate to severe postasphyxial HIE per year was 24 patients (range, 7-43 patients).
OUTCOME
Outcome data were available for a total of 345 patients (327 from the hospital records, 4 from regional follow-up clinics, 13 from primary care physicians, and 1 from the mother). The mean age at follow-up assessment was 30 months (median age, 22 months; interquartile age range, 18-36 months). Of the 345 children with outcome data, 115 died; the median age at death was 48 hours (age range, 10 hours to 86 days), and the primary cause of death was HIE in all of the cases (due to withdrawal of life support in 105 infants based on high probability of adverse outcome; 10 infants died while receiving life-sustaining treatment). Of the survivors, 111 children had severe adverse outcome, and 119 children (34%) did not have this outcome. Thus, in total, 226 children (66%) had severe adverse outcome (Figure 1) . A chronic seizure disorder or microcephaly was present at the time of assessment in 64 and 57 survivors, respectively.
PREDICTOR VARIABLE ANALYSIS
Predictive data were not available for 43 children (21 children with severe adverse outcome and 22 free of severe adverse outcome). The missing data were type of asphyxia (n=30), blood gas analysis results (n=19), and time of onset of respiration (n=1) (some children had missing data for Ͼ1 variable). Comparisons of the predictive variables indicate that the 73 children lacking data (30 children who were missing outcome data and 43 who were missing predictor variable data) had less severe neonatal illness than the 302 children with complete data ( Table 2) .
For the remaining 302 children (204 children with severe adverse outcome and 98 free of severe adverse outcome), the results of univariate and multivariable logistic regression analyses with outcome as the dependent variable are respectively reported in Table 3 and Table 4 . Six independent predictors of outcome were identified. For severe adverse outcome, the accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of the multivariable model were 73%, 89%, 41%, 76%, and 63%, respectively. The receiver operating characteristic curve (Figure 2) revealed an area under the curve of 0.74 (95% confidence interval, 0.69-0.80). The results of internal validation based on random case selection revealed accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of 74%, 89%, 39%, 77%, and 62%, respectively, for the derivation cohort and 72%, 91%, 41%, 72%, and 72%, respectively, for the validation cohort. on temporal division of the cohort revealed accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of 69%, 86%, 37%, 72%, and 58%, respectively, for the derivation cohort and 76%, 90%, 41%, 78%, and 60%, respectively, for the validation cohort.
PREDICTION RULE
The results of the logistic regression model of only 3 predictors with high statistical significance (administration of chest compressions Ͼ1 minute, onset of breathing Ͼ30 minutes, and base deficit value Ͼ16 in any blood gas analysis within the first 4 hours from birth) and of the simple count of these variables are reported in Table 5 . The observed and predicted rates of severe adverse outcome in subgroups with none, any 1, any 2, or all of the 3 of these predictors are reported in Table 6 ; a simple count of the variables individually and in various combinations correlated in a stepwise fashion with the observed (Figure 3) and predicted outcomes.
COMMENT
Using a combination of 6 markers in this cohort, we developed a model with improved sensitivity (89%) and positive predictive value (76%) for severe adverse outcome compared with our previous prediction model that was based on a smaller sample. 5 Internal validation demonstrated the robustness of the model. The prediction rule derived by a simple count of 3 variables greatly improved predictive power. These 3 predictors are known to be associated with poor long-term outcome. 31 Individual estimates of odds of severe adverse outcome associated with each of these 3 variables were similar to that of the entire cohort; however, absence of all of the 3 variables reduced the probability of severe adverse out- come by 20% from baseline, and there was an approximately 15% risk for each variable added to the count. Therapeutic decisions are based on the prognosis of the infant, which varies with the severity of illness. Gluckman et al 15 described their hesitations about enrolling babies with the most severe postasphyxial HIE (determined by amplitude-integrated EEG) to the head-cooling trial, and based on the results, they concluded that the therapy was probably not effective for patients with severe injury. Severe cases (eg, cases with 2 or all of the 3 predictor variables present) probably incur the risk of severe disability rather than death with neuroprotective therapy. In our opinion, prognostic models that offer a simple sliding scale of probability of severe adverse outcomes such as ours will be very useful in this regard for selection purposes. We agree with the speculation that clinical criteria are likely to complement amplitude-integrated EEG, 32 even when the latter is widely available.
To decide whether to institute neuroprotective therapy, predictive models are needed within the therapeutic window of 5 to 6 hours, 14 preferably by age 4 hours, to allow time for enrollment. Even a highly accurate predictive model or scoring system is not useful for experimental or clinical therapy beyond this therapeutic window. 7, 33, 34 Major issues with existing models include inadequate sample size, selection bias, timing of the model, outcome assessment, and lastly, attrition.
31, 35 Perlman 36 reviewed the measures of diagnosis and severity of asphyxia that were used during labor and in the delivery room and suggested that these markers are useful in combination to identify infants who will progress to develop HIE or seizures. Apart from an earlier study from our institution, 5 few studies have built predictive models for the first 4 hours after birth. Perlman and Risser 35 studied 96 infants with asphyxia and identified a 5-minute Apgar score of less than 5, intubation in the delivery room, and fetal acidemia as predictors of risk of seizures within 4 hours of birth in 5 patients. Carter et al 37 developed a scoring system to predict multiorgan dysfunction based on fetal heart rate abnormalities, umbilical arterial acidosis, and 5-minute Apgar score. Other nonclinical markers such as serum or urine S100 levels, 9 urinary lactate-creatinine ratio, 8 and amplitude-integrated EEG results 10, 38 have shown promise as early markers of severity of HIE, but their relationships to longterm outcome have not been tested. The need for a special assay and expertise to interpret the results may limit usefulness. Imaging modalities such as magnetic resonance imaging, magnetic resonance spectroscopy, and diffusion-weighted imaging are recommended between ages 2 to 8 days, 39 but their prognostic utility has not been established even on day 1. To interpret our results, methodological issues need consideration. Despite a rigorous selection method, we cannot exclude the presence of antenatal events in some infants. It could be argued that clinical practice and outcomes changed during the study period. However, we are not aware of any substantive change in therapy of postasphyxial HIE between 1985 and 2000 or of reports of secular changes in outcomes. No change in outcome, including the ratio of death to severe disability, was observed over time. Other factors that may cause instability of predictive models are changes in the diagnostic criteria of postasphyxial HIE 20, 21, [40] [41] [42] and the relatively low prevalence of intrapartum asphyxia as a cause of neonatal encephalopathy and CP. 18, 43 Patients lost to follow-up exhibited less severe neonatal illness and were therefore more likely to have relatively good outcomes; however, their outcomes remain uncertain. The great majority of severe adverse outcomes are diagnosed by age 12 months. Shankaran et al 44 found that neurological examination at age 12 months can predict severe disability at age 5 years. We acknowledge that variability in developmental assessment may have introduced bias; however, the severe adverse outcomes defined in this study are far from subtle and have the ability to detect major differences between groups.
The referral patterns and the eligibility criteria for this study resulted in a cohort with characteristics including outcomes similar to those in infants enrolled in neuroprotective therapy trials [15] [16] [17] and infants admitted to children's hospitals providing similar regional services. 44, 45 The inclusion of infants in our cohort with only moderate to severe encephalopathy is justified owing to the high likelihood of favorable outcomes in infants with mild encephalopathy. 46 Combining patients with moderate and severe encephalopathy allowed us to develop a pragmatic model; however, we are aware that the outcome spectrum is different for these 2 categories. The adverse outcome rate in patients with moderate and severe encephalopathy (66%) was somewhat higher than in the control groups in 2 recent clinical trials (60% 17 and 62% 15 ), presumably owing to exclusion of infants in extremis.
The advantages of our model include selection of infants with moderate to severe HIE at high risk for adverse outcomes, a low attrition rate, simplicity of variables based on available clinical and biochemical criteria, and adequate power. Despite the selection bias against patients with most predictable outcomes (those with the most severe disease and the mildest disease), our results have high predictive values with narrow confidence limits and provide a sliding scale rather than categorical criteria.
Prognostic certainty is often unattainable. In patients referred to our center even with none of the 3 predictors present, there was a 46% possibility of poor outcome. Conversely, even with all of the 3 indicators present, there was a 7% possibility that the infant would remain free of severe adverse outcome. We caution that this prediction rule should be used only for the patients who meet the eligibility criteria outlined earlier. Improved models will depend on a better definition of asphyxia, precise data on predictors, and external validation. 
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